Atlas Trials

Xylometazoline and Cocaine for Nasal Vasoconstriction

Clinical trial NCT05334017 · COMPLETED

Trial details

NCT number
NCT05334017
Sponsor
Rigshospitalet, Denmark
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Epistaxis
Start date
2022-09-08
Primary completion
2023-03-21
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.